Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSThe pharmaceutical industry has made great strides in recent years developing novel medicines, however, in Latin America, access to most of the latest innovative medications is limited, particularly in oncology and rare disease. This report outlines a solution framework aimed at improving access to medicines within Latin America and increasing critical funding for innovative medicines. The solution framework builds upon real world examples from other countries that address inequality in access to innovative oncology and rare disease therapies. Possible solutions are presented for five countries (Brazil, Mexico, Argentina, Colombia, and Costa Rica) based on their unique context and needs.
Constrained healthcare budgets in Latin America and the lack of an adequate funding framework for innovative medicines present significant hurdles to access and reimbursement for innovative medicines. Among fourteen solutions implemented globally to overcome funding challenges, four were assessed to be more feasible to implement and likely to have a greater impact on healthcare financing in Latin America. These four policy building blocks — creation of dedicated drug funds, earmarked taxes, social impact bonds and R&D capital investment through public/private partnerships — can form the foundation of a solution framework for funding innovative medicines in Latin America.
Potential application of this framework in the context of multiple countries requires some adjustments to properly fit specific country contexts. Solutions put forth for Argentina, Colombia, Mexico, Costa Rica and Brazil do not include every component of the framework, but elements of the framework provide a basis for a tailored context-specific solution that can be further evaluated with government and other stakeholders. These country-level funding frameworks target current resources that could be reallocated to meet objectives of previously passed legislation on rare disease and oncology and involve innovative funds that can generate a sustainable and traceable funding mechanism to provide resources to clinicians and patients.